Jean-Max Demiautte is an Analyst at TechLife Capital.
Before joining TechLife, he worked in quality assurance systems at the unidose specialist Unither Pharmaceuticals. He then joined Sanofi’s global medical affairs department, in charge of group's diabetes strategy
Jean-Max is a graduate pharmacist from the University of Amiens with a specialization in industry. He also holds a Master 2 in Business Administration from IAE and an ESCP Master in Biopharmaceutical Management.